Study of p53 codon 72 polymorphism in patients with breast cancer

European Journal of Gynaecological Oncology

Volumn 29, Issue 4, 2008, Pages 364-367

  Vieira, J O ^a   Da Silva, I D C G ^a   Higo, P E S ^a   Nogueira de Souza, N C ^a   Gebrim, L H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; p53 polymorphism; Prognosis

Indexed keywords

ARGININE; ESTROGEN RECEPTOR; GENOMIC DNA; PROLINE; PROTEIN P53;

ADULT; AGE; AGED; ALLELE; ARTICLE; BLOOD VESSEL; BRAZIL; BREAST CANCER; CANCER INVASION; CANCER STAGING; CHEEK; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FISHER EXACT TEST; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAZIL; BREAST NEOPLASMS; CODON; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ESTROGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 47949130949     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. ABC of breast diseases: "Breast cancer-epidemiology, risk factors and genetics". In: Harris J.R., Lippman M.E., Morrow M., Osborne C.K. (eds.). Disease of the Breast. Philadelphia: Lippincott Williams & Wilkins, 2000, 237.
2. Instituto Nacional do Câncer. Available at: http//:www.inca.gov.br, 2005.
3. Soulitzis N., Sourvinos G., Dokianakis D.N., Spandidos D.A.: "p53 codon 72 polymorphism and its association with bladder cancer". Cancer Lett., 2002, 179, 175.
4. Burns T.F., El-Deiry W.S.: "The p53 pathway and apoptosis". J. Cell. Physiol., 1999, 181, 231.
5. Drummond S.N., Pordeus I.A., Barbosa A.A., Gomez R.S.: "TP53 codon 72 polymorphism in oral squamous cell carcinoma". Anticancer Res., 2002, 22, 3379.
6. Lane D.P.: "p53 guardian of the genome". Nature, 1992, 358, 15.
7. Langerod A., Bukholm I.R.K., Bregard A., Lønning P.E., Andersen T.I., Rognum T.O. et al.: "The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas". Cancer Epidemiol., Biomark. Prev., 2002, 11, 1684.
8. Hainaut P., Hollstein M.: "p53 and human cancer: the first ten thousand mutations". Adv. Cancer Res., 2000, 77, 81.
9. Shiao Y., Chen V.W., Scheer W.D., Wu X.C., Correa P.: "Racial disparity in the association of p53 gene alterations with breast cancer survival". Cancer Res., 1995, 55, 1485.
10. Noma C., Miyoshi Y., Taguchi T., Tamaki Y., Noguchi S.: "Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women". Cancer Lett., 2004, 210, 197.
11. Papadakis E.N., Dokianakis D.N., Spandidos D.: "p53 codon 72 polymorphism as a risk factor in the development of breast cancer". Mol. Cell. Biol. Res. Commun., 2000, 3, 389.
12. Powel B.L., Staveren I.L., Roosken P., Grieu F., Berns E.M., Iacopetta B.: "Association between common polymorphisms in TP53 and p21WAF1/Cipl and phenotypic features of breast cancer". Carcinogenesis, 2002, 23, 311.
13. Matlashewski G.J., Tuck S., Pim D., Lamb P., Scheider J., Crawford L.V.: "Primary structure polymorphism at amino acid residue 72 of human p53". Mol. Cell. Biol., 1987, 7, 961.
14. Thomas M., Kalita A., Labrecque S., Pim D., Banks L., Matlashewski G.: "Two polymorphic variants of wild-type p53 differ biochemically and biologically". Mol. Cell. Biol., 1999, 1092.
15. Dokianakis D.N., Spandidos D.A.: "p53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer". Mol. Cell. Biol. Res. Commun., 2000, 3, 111.
16. Beckman G., Birgander R., Sjǎlander A., Saha N., Holmberg P.A., Kivelǎ A. et al.: "Is p53 polymorphism maintained by natural selection?". Hum. Hered., 1994, 474, 266.
17. Brenna S.M., Silva I.D., Zeferino L.C., Pereira J.S., Martinez E.Z., Syrjǎnen K.J.: "Prognostic value P53 codon 72 polymorphism in invasive cervical cancer in Brazil". Gynecol. Oncol., 2004, 93, 374.
18. rd George D.L., Murphy M.: "The codon 72 polymorphic variants of p53 have markedly different apoptotic potential". Nat. Genet., 2003, 33, 357.
19. Hildesheim A., Schiffman M., Brinton L.A., Fraumeni J.F. Jr., Herrero R., Bratti M.C. et al.: "p53 polymorphism and risk of cervical cancer". Nature, 1998, 396, 532.
20. Bonafé M., Ceccarelli C., Farabegoli F., Santini D., Taffurelli M., Barbi C. et al.: "Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients". Clin. Cancer Res., 2003, 9, 4860.
21. Furihata M., Takeuchi T., Matsumoto M., Kurabayashi A., Ohtuski Y., Terao N. et al.: "p52 mutation arising in arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract". Clin. Cancer Res., 2002, 8, 1192.
22. Yamamoto T., Oda K., Kubota K., Miyazaki K., Takenouti Y., Nimura Y. et al.: "Expression of p73 gene, cell proliferation and apoptosis in breast cancer: immunohistochemical and clinico-pathological study". Oncol. Reports, 2002, 9, 729.